Evidence map›Paper›PMID 26953212›Full record

ArticleAntimicrobial agents and chemotherapy2016

First Report of cfr-Carrying Plasmids in the Pandemic Sequence Type 22 Methicillin-Resistant Staphylococcus aureus Staphylococcal Cassette Chromosome mec Type IV Clone.

Anna C Shore, Alexandros Lazaris, Peter M Kinnevey, Orla M Brennan, Gráinne I Brennan, Brian O'Connell, Andrea T Feßler, Stefan Schwarz, David C Coleman

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Mucoid Staphylococcus haemolyticus: an unheeded multidrug-resistant pathogen.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  3. Molecular epidemiology and characterization of antimicrobial-resistantFrontiers in cellular and infection microbiology · 2023
    Article
  4. Vancomycin Resistance inMicroorganisms · 2022
    Review
  5. Pharmaceutics · 2022
    Article
  6. Communications medicine · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Pathogens (Basel, Switzerland) · 2020
    Article
  11. Livestock-Associated Methicillin-ResistantFoods (Basel, Switzerland) · 2020
    Article
  12. Methicillin-ResistantInfectious diseases · 2020
    Review
  13. Presence and Characterization of a NovelFrontiers in microbiology · 2020
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Clinical case of cfr-positive MRSA CC398 in Belgium.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2017
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Anna C ShoreMicrobiology Research Unit, Dublin Dental University Hospital, University of Dublin, Trinity College Dublin, Dublin, Ireland National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland.
Alexandros LazarisMicrobiology Research Unit, Dublin Dental University Hospital, University of Dublin, Trinity College Dublin, Dublin, Ireland.
Peter M KinneveyMicrobiology Research Unit, Dublin Dental University Hospital, University of Dublin, Trinity College Dublin, Dublin, Ireland.
Orla M BrennanMicrobiology Research Unit, Dublin Dental University Hospital, University of Dublin, Trinity College Dublin, Dublin, Ireland.
Gráinne I BrennanMicrobiology Research Unit, Dublin Dental University Hospital, University of Dublin, Trinity College Dublin, Dublin, Ireland National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland.
Brian O'ConnellNational MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland Department of Clinical Microbiology, School of Medicine, Trinity College Dublin, St. James's Hospital, Dublin, Ireland.
Andrea T FeßlerInstitute of Farm Animal Genetics, Friedrich Loeffler Institut, Neustadt-Mariensee, Germany.
Stefan SchwarzInstitute of Farm Animal Genetics, Friedrich Loeffler Institut, Neustadt-Mariensee, Germany.
David C ColemanMicrobiology Research Unit, Dublin Dental University Hospital, University of Dublin, Trinity College Dublin, Dublin, Ireland david.coleman@dental.tcd.ie.ORCID 0000-0003-1797-2888
Trinity College Dublin · IEFriedrich-Loeffler-Institut · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Linezolid is often the drug of last resort for serious methicillin-resistant Staphylococcus aureus (MRSA) infections. Linezolid resistance is mediated by mutations in 23S rRNA and genes for ribosomal proteins; cfr, encoding phenicol, lincosamide, oxazolidinone, pleuromutilin, and streptogramin A (PhLOPSA) resistance; its homologue cfr(B); or optrA, conferring oxazolidinone and phenicol resistance. Linezolid resistance is rare in S. aureus, and cfr is even rarer. This study investigated the clonality and linezolid resistance mechanisms of two MRSA isolates from patients in separate Irish hospitals. Isolates were subjected to cfr PCR, PhLOPSA susceptibility testing, 23S rRNA PCR and sequencing, DNA microarray profiling, spa typing, pulsed-field gel electrophoresis (PFGE), plasmid curing, and conjugative transfer. Whole-genome sequencing was used for single-nucleotide variant (SNV) analysis, multilocus sequence typing, L protein mutation identification, cfr plasmid sequence analysis, and optrA and cfr(B) detection. Isolates M12/0145 and M13/0401 exhibited linezolid MICs of 64 and 16 mg/liter, respectively, and harbored identical 23S rRNA and L22 mutations, but M12/0145 exhibited the mutation in 2/6 23S rRNA alleles, compared to 1/5 in M13/0401. Both isolates were sequence type 22 MRSA staphylococcal cassette chromosome mec type IV (ST22-MRSA-IV)/spa type t032 isolates, harbored cfr, exhibited the PhLOPSA phenotype, and lacked optrA and cfr(B). They differed by five PFGE bands and 603 SNVs. Isolate M12/0145 harbored cfr and fexA on a 41-kb conjugative pSCFS3-type plasmid, whereas M13/0401 harbored cfr and lsa(B) on a novel 27-kb plasmid. This is the first report of cfr in the pandemic ST22-MRSA-IV clone. Different cfr plasmids and mutations associated with linezolid resistance in genotypically distinct ST22-MRSA-IV isolates highlight that prudent management of linezolid use is essential.

Indexed as

Anti-Bacterial AgentsChromosomes, BacterialDrug Resistance, Multiple, BacterialMethicillin-Resistant Staphylococcus aureusPlasmidsRNA, Ribosomal, 23SStaphylococcal InfectionsStaphylococcus aureusAnti-Bacterial AgentsRNA, Ribosomal, 23S

Identifiers

PMID26953212
PMCPMC4862533
OpenAlexW2293326587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.